Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
VRCA holding history
Verrica Pharmaceuticals Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRCA overviewAll 13F holders of VRCAFull Q2 2026 holdings
- Shares (Q2 2026)
- 21,769
- Value
- $133.2K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 21,769 | $133.2K | <0.1% | −10,591−32.7% | Reduced | Holders |
| Q1 2026 | 32,360 | $171.2K | <0.1% | +5,960+22.6% | Added | Holders |
| Q4 2025 | 26,400 | $219.4K | <0.1% | −2,791−9.6% | Reduced | Holders |
| Q3 2025 | 29,191 | $125.8K | <0.1% | +20,471+234.8% | AddedConverted for a 1-for-10 split | Holders |
| Q2 2025 | 87,200 | $46.2K | <0.1% | +87,200 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −233,300−100.0% | Sold out | Holders |
| Q4 2024 | 233,300 | $163.3K | <0.1% | +85,336+57.7% | Added | Holders |
| Q3 2024 | 147,964 | $214.5K | <0.1% | +102,439+225.0% | Added | Holders |
| Q2 2024 | 45,525 | $331.9K | <0.1% | +45,525 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −68,100−100.0% | Sold out | Holders |
| Q3 2023 | 68,100 | $265.0K | <0.1% | −91,200−57.3% | Reduced | Holders |
| Q2 2023 | 159,300 | $919.0K | <0.1% | +102,800+181.9% | Added | Holders |
| Q1 2023 | 56,500 | $367.0K | <0.1% | −99,874−63.9% | Reduced | Holders |
| Q4 2022 | 156,374 | $430.0K | <0.1% | −73,926−32.1% | Reduced | Holders |
| Q3 2022 | 230,300 | $672.0K | <0.1% | +182,400+380.8% | Added | Holders |
| Q2 2022 | 47,900 | $92.0K | <0.1% | +47,900 | New | Holders |